key articles
Expression of VEGF and VEGF receptors linked with BCa stage and recurrence
Wednesday, 12 June 2013- Vascular endothelial growth factor (VEGF) signaling is frequently altered in invasive tumor cells and is associated with patient outcome.
In their study P. K. Kopparapu and colleagues examined VEGF,...
Posted by: JV
Fruit and veggie consumption linked to lower risk of BCa among women
Monday, 10 June 2013- Fruits and vegetables have been examined for their possible effects on the risk of bladder cancer, as they contain numerous nutrients, phytochemicals, and antioxidants with potentially anticarcinogenic...
Posted by: JV
Robotics do not reduce complications in cystectomy
Monday, 13 May 2013- A randomized trial comparing robotic with open cystectomy ended early after an interim analysis showed the minimally invasive approach did not reduce complications, according to a study reported...
Posted by: JV
In bladder cancer metastasis, ‘messenger’ molecule makes a big difference in tumour growth
Monday, 15 April 2013- In order to kill, bladder cancer must metastasize, most commonly to the lung - what are the differences between bladder cancers that do and do not make this deadly transition?
Research presented by the...
Posted by: JV
Specialised telerobotic system designed to treat bladder cancer
Monday, 8 April 2013- Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years.
An...
Posted by: JV
Predictors of the use of orthotopic bladder reconstruction after radical cystectomy for bladder cancer
Wednesday, 27 February 2013- How often orthotopic reconstruction should be used after radical cystectomy is uncertain. Male sex, younger age, affluence, white ethnicity and treatment in specialist hospitals may be associated with...
Posted by: JV
Predicting progression of bladder urothelial carcinoma using microRNA expression
Monday, 18 February 2013- Recurrence and progression prediction in urothelial cancer is currently based on clinical and pathological factors: tumour grade, tumour stage, number of lesions, tumour size, previous recurrence rate,...
Posted by: JV
Pioglitazone and risk of bladder cancer
Tuesday, 5 February 2013- Pioglitazone, a thiazolidinedione, was approved for treatment of Type 2 diabetes. However, several observational studies suggest an association of pioglitazone with an increased risk of bladder cancer in...
Posted by: JV
Comparison of adaptive radiotherapy techniques for bladder cancer treatment
Tuesday, 8 January 2013- Day-to-day anatomical variations complicate bladder cancer radiotherapy treatment.
In their study, G. Webster and colleagues quantified the impact on target coverage and irradiated normal tissue volume...
Posted by: JV
4th EMUC Preview: issues in locally advanced bladder cancer
Thursday, 15 November 2012- At the 4th European Multidisciplinary Meeting on Urological Cancers (EMUC) which will open tomorrow in Barcelona, Spain, uro-oncology experts will closely examine treatment options in agressive bladder...
By Joel Vega
